Mercer Global Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Buy |
17,712
+1,909
| +12% | +$549K | 0.01% | 536 |
|
|
2025
Q1 | $4.87M | Buy |
15,803
+243
| +2% | +$74.9K | 0.01% | 547 |
|
|
2024
Q4 | $5.49M | Buy |
15,560
+217
| +1% | +$76.6K | 0.01% | 518 |
|
|
2024
Q3 | $5.49M | Buy |
15,343
+1,425
| +10% | +$510K | 0.01% | 480 |
|
|
2024
Q2 | $4.43M | Buy |
13,918
+2,013
| +17% | +$641K | 0.01% | 480 |
|
|
2024
Q1 | $2.74M | Sell |
11,905
-377
| -3% | -$86.6K | 0.01% | 635 |
|
|
2023
Q4 | $2.7M | Buy |
12,282
+131
| +1% | +$28.8K | 0.01% | 642 |
|
|
2023
Q3 | $2.75M | Buy |
12,151
+2,237
| +23% | +$505K | 0.01% | 604 |
|
|
2023
Q2 | $2.19M | Buy |
9,914
+933
| +10% | +$206K | 0.01% | 705 |
|
|
2023
Q1 | $2.01M | Buy |
8,981
+706
| +9% | +$158K | 0.01% | 678 |
|
|
2022
Q4 | $2.3M | Sell |
8,275
-39
| -0.5% | -$10.8K | 0.01% | 656 |
|
|
2022
Q3 | $1.74M | Sell |
8,314
-92
| -1% | -$19.3K | 0.01% | 661 |
|
|
2022
Q2 | $1.98M | Sell |
8,406
-13
| -0.2% | -$3.06K | 0.01% | 614 |
|
|
2022
Q1 | $1.51M | Sell |
8,419
-1,285
| -13% | -$230K | 0.01% | 743 |
|
|
2021
Q4 | $2.1M | Buy |
9,704
+524
| +6% | +$113K | 0.01% | 605 |
|
|
2021
Q3 | $1.69M | Buy |
9,180
+339
| +4% | +$62.6K | 0.01% | 667 |
|
|
2021
Q2 | $1.59M | Buy |
8,841
+868
| +11% | +$156K | 0.01% | 655 |
|
|
2021
Q1 | $1.33M | Buy |
7,973
+2,889
| +57% | +$483K | 0.01% | 681 |
|
|
2020
Q4 | $772K | Buy |
5,084
+2,169
| +74% | +$329K | 0.01% | 702 |
|
|
2020
Q3 | $294K | Buy |
2,915
+212
| +8% | +$21.4K | ﹤0.01% | 974 |
|
|
2020
Q2 | $327K | Buy |
+2,703
| New | +$327K | 0.01% | 819 |
|
|
2020
Q1 | – | Sell |
-7,696
| Closed | -$678K | – | 1252 |
|
|
2019
Q4 | $678K | Buy |
7,696
+802
| +12% | +$70.7K | 0.01% | 629 |
|
|
2019
Q3 | $549K | Buy |
6,894
+2,095
| +44% | +$167K | 0.01% | 658 |
|
|
2019
Q2 | $375K | Buy |
4,799
+410
| +9% | +$32K | 0.01% | 791 |
|
|
2019
Q1 | $515K | Buy |
+4,389
| New | +$515K | 0.02% | 617 |
|